Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 06, 2015 1:10 PM ET

Life Sciences Tools and Services

Company Overview of Adaptive Biotechnologies Corporation

Company Overview

Adaptive Biotechnologies Corporation engages in immune-based discoveries and diagnostics by developing sequencing assays for research and drug development needs. It offers an immunoSEQ hsTCRB kit and analyzer to profile T-cell and B-cell receptor genes. The company provides tools and services for researchers and clinicians (at academic centers and biopharmaceutical companies) to diagnose, treat, and monitor patients with cancers, minimal residual diseases, autoimmune disorders, infectious diseases, and other immune-mediated diseases via its proprietary immune profiling sequencing technology. It serves customers worldwide. Adaptive Biotechnologies Corporation was formerly known as Adaptive TC...

1551 Eastlake Avenue East

Suite 200

Seattle, WA 98102

United States

Founded in 2009





Key Executives for Adaptive Biotechnologies Corporation

Founder, Chief Executive Officer, President and Director
Chief Financial Officer, Director and Chairman of Audit Committee
Age: 40
Senior Vice President of Operations
Compensation as of Fiscal Year 2015.

Adaptive Biotechnologies Corporation Key Developments

Adaptive Biotechnologies Replaces Dean Schorno with Chad Cohen as Chief Financial Officer

Adaptive Biotechnologies announced the appointment of Chad Cohen as its new Chief Financial Officer, effective immediately. Most recently, Mr. Cohen served as CFO for Zillow Group, where he oversaw all finance, treasury and accounting functions and led the finance organization through Zillow's 2011 IPO and nine acquisitions. Dean Schorno, the company’s preceding CFO, will step down to pursue a local opportunity in the San Francisco Bay Area where he resides.

Adaptive Biotechnologies Corporation Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:00 AM

Adaptive Biotechnologies Corporation Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:00 AM. Venue: The St. Regis Deer Valley, Park City, Utah, United States. Speakers: Chad Robins, Founder, Chief Executive Officer, President and Director.

Adaptive Biotechnologies Corporation Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 09:50 AM

Adaptive Biotechnologies Corporation Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 09:50 AM. Venue: Hyatt Chicago Magnificent Mile, Chicago, Illinois, United States. Speakers: Sharon Benzeno, Senior Director, New Product Development.

Similar Private Companies By Industry

Company Name Region
Active Life Technologies LLC United States
DisperSol Technologies LLC United States
Accuri Cytometers, Inc. United States
American Stem Cell Corporation United States
Genotox Laboratories, Ltd. United States

Recent Private Companies Transactions

Private Placement
May 5, 2015
Private Placement
January 7, 2015
January 7, 2015
Sequenta, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adaptive Biotechnologies Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at